佩拉曼尼尔在耐火和超耐火状态患者的疗效与疑似炎症病因:一个案例系列
Annacarmen Nilo1,2, Alberto Vogrig1,2, Marco Belluzzo3
1Clinical Neurology Unit, Department of Head, Neck and Neurosciences, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy.
在其他药物失败时,佩拉曼尼尔有效治疗炎症或自身免疫原因的患者的耐火性 (SE). 这表明perampanel可能是这些特定的SE类型的有价值的治疗选择.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 佩拉曼奈尔 (PER) 通过减少促炎细胞因子和亡,表现出抗炎和神经保护性质.
- 它在治疗具有炎症起源的状态 (SE) 的潜力需要进一步研究.
研究的目的:
- 为了评估perampanel在耐火和超耐火状态的炎症或自身免疫病因的患者中的疗效.
主要方法:
- 对七名耐火性/超耐火性SE患者进行了回顾性分析,这些患者接受了perampanel治疗.
- 由于可能或确定的炎症或自身免疫原因,患者患有SE.
- 佩拉曼奈尔作为第三线或第四线治疗.
主要成果:
- 所有七名患者在服用帕拉曼内尔后都实现了SE解决.
- 大多数 (57.1%) 的问题在24小时内得到解决.
- 在5名患者中,SE是焦点的,在2名患者中是普遍的,原因包括系统性炎症和自身免疫性疾病.
结论:
- 佩拉曼奈尔在治疗对一线和二线抗发作药物不耐用的SE治疗中表现出有效性.
- 结果表明,在SE病例中,在炎症或自身免疫病因方面,应考虑更早地使用帕拉曼尼尔.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
